Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.5 $21,577 - $32,365
21,577 Added 83.52%
47,410 $63,000
Q3 2023

Nov 14, 2023

BUY
$1.03 - $1.85 $26,607 - $47,791
25,833 New
25,833 $27,000
Q1 2023

May 15, 2023

SELL
$1.39 - $3.24 $32,574 - $75,929
-23,435 Reduced 61.22%
14,848 $21,000
Q4 2022

Feb 14, 2023

BUY
$2.32 - $3.68 $24,199 - $38,386
10,431 Added 37.45%
38,283 $96,000
Q3 2022

Nov 14, 2022

BUY
$2.87 - $7.01 $79,935 - $195,242
27,852 New
27,852 $89,000
Q2 2022

Aug 16, 2022

SELL
$3.76 - $6.29 $292,332 - $489,034
-77,748 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$5.03 - $9.61 $88,291 - $168,684
17,553 Added 29.16%
77,748 $480,000
Q2 2021

Aug 16, 2021

BUY
$7.16 - $9.56 $315,269 - $420,945
44,032 Added 272.42%
60,195 $497,000
Q1 2021

May 18, 2021

BUY
$8.52 - $19.21 $39,430 - $88,903
4,628 Added 40.12%
16,163 $154,000
Q4 2020

Feb 17, 2021

SELL
$9.3 - $15.19 $435,230 - $710,876
-46,799 Reduced 80.23%
11,535 $107,000
Q3 2020

Nov 17, 2020

SELL
$8.24 - $30.8 $78,749 - $294,355
-9,557 Reduced 14.08%
58,334 $793,000
Q1 2020

May 15, 2020

BUY
$0.91 - $17.81 $61,780 - $1.21 Million
67,891 New
67,891 $517,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $43.2M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.